Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin.
Principal Investigator
Shiga-Toxigenic Escherichia coli
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. N Engl J Med. 2016 11 17; 375(20):1946-1960.
View in:
PubMed
subject areas
Adult
Crohn Disease
Female
Humans
Induction Chemotherapy
Infusions, Intravenous
Maintenance Chemotherapy
Male
Middle Aged
Remission Induction
Ustekinumab
authors with profiles
Stephen B. Hanauer